Last reviewed · How we verify

Universität Duisburg-Essen — Portfolio Competitive Intelligence Brief

Universität Duisburg-Essen pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
caraway oil caraway oil marketed Herbal/botanical preparation Gastroenterology
Individualized internal ayurvedic treatment Individualized internal ayurvedic treatment phase 3

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Rosenberg European Academy of Ayurveda · 1 shared drug class
  2. Weleda AG · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universität Duisburg-Essen:

Cite this brief

Drug Landscape (2026). Universität Duisburg-Essen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universit-t-duisburg-essen. Accessed 2026-05-17.

Related